Literature DB >> 1604242

M. tuberculosis-complex specific T-cell stimulation and DTH reactions induced with a peptide from the 38-kDa protein.

H M Vordermeier1, D P Harris, P K Mehrotra, E Roman, A Elsaghier, C Moreno, J Ivanyi.   

Abstract

An immunodominant T-cell-stimulatory epitope located near the carboxy terminus of the 38-kDa antigen from M. tuberculosis (38.G, residues 350-369) was found to be M. tuberculosis-complex specific. This was demonstrated by the presence of proliferative and delayed type hypersensitivity (DTH) responses in mice immunized with Mycobacterium tuberculosis and Mycobacterium bovis BCG, whereas mice immunized with M. avium or other non-tuberculous species of mycobacteria showed no such responses. Peptide 38.G stimulated the proliferation of peripheral blood lymphocytes from healthy purified protein derivative (PPD)-positive individuals but not from PPD-negative individuals. It also elicited DTH responses in M. tuberculosis sensitized mice and in PPD-positive healthy human volunteers. Peptide 38.G could therefore prove to be an important component in any new molecularly defined reagent used in the immunodiagnosis of tuberculous infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1604242     DOI: 10.1111/j.1365-3083.1992.tb02979.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  A comparison of the T cell delayed-type hypersensitivity epitopes of the 19-kD antigens from Mycobacterium tuberculosis and Myco. intracellulare using overlapping synthetic peptides.

Authors:  J C Mackall; G H Bai; D A Rouse; G R Armoa; F Chuidian; J Nair; S L Morris
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

2.  Delayed-type hypersensitivity elicited by synthetic peptides complexed with Mycobacterium tuberculosis hsp 70.

Authors:  E Roman; C Moreno
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

3.  Evaluation of gamma interferon immune response elicited by the newly constructed PstS-1(285-374):CFP10 fusion protein to detect Mycobacterium tuberculosis infection.

Authors:  Leonardo Silva de Araujo; Fernanda Carvalho de Queiroz Mello; Nidai de Bárbara Moreira da Silva; Janaina Aparecida Medeiros Leung; Silvia Maria Almeida Machado; Isabela Gama Sardella; Renata de Moraes Maciel; Maria Helena Féres Saad
Journal:  Clin Vaccine Immunol       Date:  2014-02-12

Review 4.  Leprosy, tuberculosis, and the new genetics.

Authors:  D B Young; S T Cole
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

Review 5.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

6.  Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis.

Authors:  T Oettinger; A Holm; I M Mtoni; A B Andersen; K Hasløov
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Nucleotide sequence analysis and serologic characterization of a 27-kilodalton Mycobacterium intracellulare lipoprotein.

Authors:  J Nair; D A Rouse; S L Morris
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

8.  The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection.

Authors:  Avi-Hai Hovav; Jacob Mullerad; Liuba Davidovitch; Yolanta Fishman; Fabiana Bigi; Angel Cataldi; Herve Bercovier
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Defects in antigen-driven lymphocyte responses in common variable immunodeficiency (CVID) are due to a reduction in the number of antigen-specific CD4+ T cells.

Authors:  M Funauchi; J Farrant; C Moreno; A D Webster
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

10.  Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer.

Authors:  Christian Sänger; Andreas Busche; Gabriele Bentien; Ralf Spallek; Fatima Jonas; Andreas Böhle; Mahavir Singh; Sven Brandau
Journal:  BMC Cancer       Date:  2004-11-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.